Rapid Dose Therapeutics Corp.

DOSE

CA75339A1012

Medical Equipment, Supplies & Distribution

Market Closed - Canadian Securities Exchange Other stock markets 20:28:32 24/05/2024 BST			5-day change	1st Jan Change
0.24 ^CAD	+9.09%		+2.13%	+45.45%

03-25	Rapid Dose Therapeutics Corp. announced that it expects to receive CAD 6 million in funding	CI
02-08	Rapid Dose Therapeutics Corp. Appoints Angela O'Leary to the Board of Directors	CI

CSE Bulletin: Reinstatement - Rapid Dose Therapeutics Corp. (DOSE)

May 04, 2023 at 04:10 pm

Toronto, Ontario--(Newsfile Corp. - Le 4 mai/May 2023) - Effective immediately, Rapid Dose Therapeutics Corp. will be reinstated for trading.

The Company has rectified the situation that gave rise to the suspension.

_________________________________

Avec effet immédiat, Rapid Dose Therapeutics Corp. sera réintégré aux fins de négociation.

La Société a rectifié la situation ayant donné lieu à la suspension.

Date :	Le 4 mai/May 2023
Symbol(s)/Symbole(s) :	DOSE

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com.

Si vous avez des questions ou si vous avez besoin d'informations supplémentaires, veuillez contacter le service des inscriptions au 416 367-7340 ou par courriel l’adresse: Listings@thecse.com.

Latest news about Rapid Dose Therapeutics Corp.

Rapid Dose Therapeutics Corp. announced that it expects to receive CAD 6 million in funding	03-24	CI
Rapid Dose Therapeutics Corp. Appoints Angela O'Leary to the Board of Directors	02-08	CI
Rapid Dose Therapeutics Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2023	01-29	CI
Rapid Dose Therapeutics Corp. announced that it expects to receive CAD 7.000001 million in funding	01-18	CI
Rapid Dose Therapeutics Corp. announced that it has received CAD 3.134445 million in funding	12-21	CI
Rapid Dose Therapeutics Corp. Reports Earnings Results for the Second Quarter and Six Months Ended August 31, 2023	29/10/23	CI
Rapid Dose Therapeutics Corp. Announces the Resignation of Andrew Duckman from the Company's Board of Directors	22/09/23	CI
Rapid Dose Therapeutics Corp. Reports Earnings Results for the First Quarter Ended May 28, 2023	27/07/23	CI
Rapid Dose Therapeutics Narrows Fiscal Q4 Loss, Revenue Grows	29/06/23	MT
Rapid Dose Therapeutics Corp. Auditor Raises 'Going Concern' Doubt	27/06/23	CI
Rapid Dose Therapeutics Corp. Reports Earnings Results for the Full Year Ended February 28, 2023	27/06/23	CI
Rapid Dose Increased Proposed Private Placement Financing of Up to $5 Million; Gained 30% on Tuesday	14/06/23	MT
Rapid Dose Therapeutics Corp. announced that it expects to receive CAD 3 million in funding	01/06/23	CI
Rapid Dose Therapeutics Corp. Launches QuickStrip™ Dental Products in the Canadian Market	10/05/23	CI
Rapid Dose Therapeutics Corp. Announces Changes to Its Board of Directors	14/04/23	CI
Rapid Dose Therapeutics Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2022	30/01/23	CI
Rapid Dose Therapeutics Corp. Auditor Raises 'Going Concern' Doubt	26/01/23	CI
Rapid Dose Therapeutics Corp. Reports Earnings Results for the First Quarter Ended May 31, 2022	26/01/23	CI
Rapid Dose Therapeutics Brief: Says Co and its Auditors Continuing to work "diligently" to complete Audit of Annual financial statements for the fiscal year ended February 28, 2022	10/01/23	MT
Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order	30/12/22	MT
Rapid Dose Therapeutics Corp. Enters Supplier and Purchase Agreement with A Leading Gas and Convenience Store Retailer for Nutraceutical and Vitamin Products	23/09/22	CI
Rapid Dose Therapeutics Corp. announced that it expects to receive CAD 5 million in funding	25/05/22	CI
Rapid Dose Therapeutics Corp. announced a financing transaction	24/05/22	CI
Rapid Dose Therapeutics Corp. Provides Shareholder Update Regarding Vaccine Collaboration Agreement with Oakland Health Limited in the United Kingdom	12/05/22	CI
Rapid Dose Therapeutics Corp. and Skycare Compounding Labs to Provide Patients with Novel Oral Delivery Option for Pharmaceutical Products	26/04/22	CI

Chart Rapid Dose Therapeutics Corp.

Duration

Period

More charts

Rapid Dose Therapeutics Corp. is a Canadian biotechnology company. The Company provides disruptive drug delivery technologies designed to improve patient outcomes. The Companyâs flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient. It offers over-the-counter and pharmaceutical drug delivery solutions. Its QuickStrip Energy delivers energizing caffeine. Its QuickStrip B12 delivers vitamin B12 to the system, assisting with metabolism and physical energy. Its QuickStrip Sleep delivers melatonin to the system, inducing natural and healthy sleep. QuickStrip Lidocaine is its dental product. The Company also provides production and consultation to the nutraceutical, cannabis healthcare and pharmaceutical manufacturing industries.

Sector

Medical Equipment, Supplies & Distribution

Calendar

29/07/2024 - Q1 2025 Earnings Release (Projected)

More about the company